RIPOR2 promotes multinucleation of melanoma cells downstream of the RAS/ERK oncogenic pathway
Axelle Wilmerding, Aurélie Richard, Nicolas Macagno…·Marie-Claire Delfini
This study identifies RIPOR2 as a downstream target of the RAS/ERK pathway that promotes multinucleation in melanoma cells, contributing to aneuploidy and tumor progression.